Q2 Holdings officer logs stock awards and tax sales
Q2 Holdings, Inc. Chief Delivery Officer John E. Breeden reported a mix of stock awards and mandated sales.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Q2 Holdings, Inc. Chief Delivery Officer John E. Breeden reported a mix of stock awards and mandated sales. He received two grants of common stock totaling tens of thousands of shares at no cost upon vesting of performance-based restricted stock units tied to EBITDA and stock-price benchmarks. To cover tax withholding from these vestings, he sold 41,966 shares of common stock in open-market transactions at weighted-average prices around $49.7 per share. After these transactions, he directly owned 159,019 shares of Q2 Holdings common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 33,445 | $49.75 | $1.66M |
| Sale | Common Stock | 8,521 | $49.72 | $424K |
| Grant/Award | Common Stock | 24,646 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 26,696 | $0.00 | $0.00 |
Footnotes (4)
- F1. Represents shares received, in excess of the target number ("Target Amount") of shares previously reported on Form 4, upon the final vesting of performance-based restricted stock units originally granted on March 2, 2023 ("Units"). As previously disclosed, subject to continued employment, up to 100% of the Target Amount of shares was scheduled to vest on the second anniversary, with the performance multiplier shares schedule to vest on the third anniversary. On the second year the number of Units that actually vested was to be up to 100% of the Target Amount, and in the third year the number of Units that actually could vest would be up to 200% of the Target Amount, in each case depending upon the performance of Q2 Holdings, Inc.'s Adjusted EBITDA of Revenue, as more specifically set forth in the grant agreement.
- F2. The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units, and it does not represent a discretionary trade by the Reporting Person.
- F3. Represents shares received, in excess of the target number ("Target Amount") of shares previously reported on Form 4, upon the final vesting of performance-based restricted stock units originally granted on March 2, 2023 ("Units"). As previously disclosed, subject to continued employment, on the third anniversary the number of Units that actually could vest would be up to 200% of the Target Amount, in each case depending upon the performance of Q2 Holdings, Inc.'s common stock price as compared to the S&P Software & Services Industry Index, as more specifically set forth in the grant agreement.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.75 to $50.05 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did QTWO Chief Delivery Officer John E. Breeden report?
What type of stock awards did QTWO grant to John E. Breeden in this filing?
What performance conditions affected John E. Breeden’s QTWO stock unit vesting?
AI-generated analysis. How Rhea-AI works. Not financial advice.